Update on triple negative breast cancer - http://pharmastrategyblog.com/2011...
Jul 12, 2011
from
Sally Church
Interested in Pharma, Biotech, Science and cancer... Find me at http://www.pharmastrategyblog.com also love food, wine, the NFL and cricket. Hi!
Using social media to improve awareness of clinical trials in rare lymphomas - http://pharmastrategyblog.com/2011...
Jul 8, 2011
from
Self-Educated Patients and The Future of Cancer Care - http://pharmastrategyblog.com/2011...
Jul 5, 2011
from
Should Pharma and Biotech be engaging in social media? - http://pharmastrategyblog.com/2011...
Jul 1, 2011
from
National Lung Cancer Screening results and their potential impact - http://pharmastrategyblog.com/2011...
Jun 30, 2011
from
ODAC votes against unanimously Genentech and Avastin in metastatic breast cancer - http://pharmastrategyblog.com/2011...
Jun 29, 2011
from
Biotechnology, Genomics and Personalized Medicine - http://pharmastrategyblog.com/2011...
Jun 29, 2011
from
Some thoughts on cancer research and the pipeline cliff… - http://pharmastrategyblog.com/2011...
Jun 28, 2011
from
On the future of cancer treatment and research - http://pharmastrategyblog.com/2011...
Jun 27, 2011
from
Does maintenance therapy with chemotherapy improve PFS in non-squamous lung cancer? - http://pharmastrategyblog.com/2011...
Jun 24, 2011
from
MET amplifications and resistance to EGFR therapy in lung cancer - http://pharmastrategyblog.com/2011...
Jun 23, 2011
from
Update on new targets in squamous cell carcinoma of the lung - http://pharmastrategyblog.com/2011...
Jun 22, 2011
from
Update on EGFR inhibitors, KRAS and T790M mutations in lung cancer - http://pharmastrategyblog.com/2011...
Jun 21, 2011
from
Update on emerging therapies in ALK+ lung cancer - http://pharmastrategyblog.com/2011...
Jun 20, 2011
from
FGFR1 mutations in squamous cell lung cancer - http://pharmastrategyblog.com/2011...
Jun 17, 2011
from
tracks:
Secret Knives - The Northwest States
(Their debut album is available for free on their site.) - http://maverickny.tumblr.com/post...
Jun 16, 2011
from
Is NOTCH a new target in leukemia? - http://pharmastrategyblog.com/2011...
Jun 16, 2011
from
Gastroenterology Article | Pancreatic Neoplasms - http://www.mdlinx.com/gastroe...
Jun 15, 2011
from
Clusterin Confers Gemcitabine Resistance in Pancreatic Cancer - http://is.gd/S7tqaO – ACOR Cancer News (cancer_news) http://twitter.com/cancer_...
- Sally Church
Pharmacy Article | Colorectal Neoplasms - http://www.mdlinx.com/pharmac...
Jun 15, 2011
from
Bevacizumab in First-line Therapy of Metastatic Colorectal Cancer: A Retrospective Comparison of FOLFIRI and XELIRI - http://is.gd/rrEbrp – ACOR Cancer News (cancer_news) http://twitter.com/cancer_...
- Sally Church
Pharmacy Article | Colorectal Neoplasms - http://www.mdlinx.com/pharmac...
Jun 15, 2011
from
Bevacizumab in First-line Therapy of Metastatic Colorectal Cancer: A Retrospective Comparison of FOLFIRI and XELIRI - http://is.gd/rrEbrp
– ACOR Cancer News (cancer_news) http://twitter.com/cancer_...
- Sally Church
Gastroenterology Article | Pancreatic Neoplasms - http://www.mdlinx.com/gastroe...
Jun 15, 2011
from
Clusterin Confers Gemcitabine Resistance in Pancreatic Cancer - http://is.gd/S7tqaO
– ACOR Cancer News (cancer_news) http://twitter.com/cancer_...
- Sally Church
@nparmalee @matthewherper that will likely be in this doc http://1.usa.gov/mMQ5bz - http://www.fda.gov/downloa...
Jun 15, 2011
from
@nparmalee @matthewherper that will likely be in this doc http://1.usa.gov/mMQ5bz
- Sally Church
@nparmalee @matthewherper that will likely be in this doc http://1.usa.gov/mMQ5bz - http://www.fda.gov/downloa...
Jun 15, 2011
from
@nparmalee @matthewherper that will likely be in this doc http://1.usa.gov/mMQ5bz
- Sally Church
EHA 2011 Patient Advocacy Session on Cancer Drug Adherence | Biotech Strategy Blog - http://biotechstrategyblog.com/2011...
Jun 15, 2011
from
RT @3NT: Excellent patient advocacy session at #EHA11 on how drug adherence may impact cancer treatment outcome http://3NT.co/lSsRld
- Sally Church
EHA 2011 Patient Advocacy Session on Cancer Drug Adherence | Biotech Strategy Blog - http://biotechstrategyblog.com/2011...
Jun 15, 2011
from
RT @3NT: Excellent patient advocacy session at #EHA11 on how drug adherence may impact cancer treatment outcome http://3NT.co/lSsRld
- Sally Church
Jun 15, 2011
from
5 awesome blog posts on how to back up your social data cc @AuroraGG @alyssagregory @usegraymatter @Green Marketing http://ht.ly/5i0bb – Sherry Nouraini (snouraini) http://twitter.com/snourai...
- Sally Church
Jun 15, 2011
from
5 awesome blog posts on how to back up your social data cc @AuroraGG @alyssagregory @usegraymatter @Green Marketing http://ht.ly/5i0bb
– Sherry Nouraini (snouraini) http://twitter.com/snourai...
- Sally Church
T-Mobile’s best phone right now? The HTC Sensation 4G — Mobile Technology News - http://gigaom.com/mobile...
Jun 15, 2011
from
$50 coupon code for the HTC #Sensation4G: http://bit.ly/m5Np7C That's a lotta phone for $149: http://bit.ly/jgT7l4 – Kevin C. Tofel (KevinCTofel) http://twitter.com/KevinCT...
- Sally Church
Take $50 Off Your Sensation 4G T-Mobile.com Order! - http://www.tmonews.com/2011...
Jun 15, 2011
from
$50 coupon code for the HTC #Sensation4G: http://bit.ly/m5Np7C That's a lotta phone for $149: http://bit.ly/jgT7l4
– Kevin C. Tofel (KevinCTofel) http://twitter.com/KevinCT...
- Sally Church
Spoonful of Medicine: Translational science awards raise questions about the NIH’s new drug development center - http://blogs.nature.com/nm...
Jun 15, 2011
from
RT @Rndubois: Translational science awards raise questions about the NIH’s new drug development center: http://t.co/HFufIYs
- Sally Church
QIAGEN makes proposal to fully acquire Ipsogen, further expanding leadership in oncology molecular diagnostics - FierceMedicalDevices - http://www.fiercemedicaldevices.com/press-r...
Jun 15, 2011
from
QIAGEN makes proposal to buy Ipsogen, further expanding into oncology molecular diagnostics. http://bit.ly/lRG3yN
– FierceMedicalDevices (FierceMedDev) http://twitter.com/FierceM...
- Sally Church